KIF15
protein-codingkinesin family member 15, the group of Kinesins
Gene summary
Predicted to enable ATP hydrolysis activity; microtubule binding activity; and plus-end-directed microtubule motor activity. Predicted to be involved in centrosome separation; microtubule-based movement; and mitotic spindle assembly. Located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
- KNSL7
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~111.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0859570
Submitter: PanelApp Australia
Inheritance Pattern: Unknown
Disease ID:MONDO:0859570
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Audiologic/Otolaryngologic
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KIF15 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_020242.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | 3 | 11 | |||
| missense | 149 | 11 | 7 | 167 | ||
| nonsense | 1 | 1 | 3 | 5 | ||
| start loss | 0 | |||||
| frameshift | 3 | 3 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 7 | 8 | |||
| Total | 1 | 2 | 162 | 19 | 10 | 194 |
Highest pathogenic variant AF is 0.000011197902
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_064627.1 | 35 | MANE Select | |
| Ensembl | ENSP00000324020.4 | 35 | MANE Select | |
| Ensembl | ENSP00000391205.1 | 6 | Standard | |
| Ensembl | ENSP00000389982.1 | 26 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| kif15 | Danio rerio | Structure: neuron Quality: decreased branchiness abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Gastric Cancer Network 1
- Vesicle-mediated transport
- role of ran in mitotic spindle regulation
- Membrane Trafficking
- Kinesins
Biological Process
- mitotic cell cycle
- retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
- microtubule-based movement
- cell population proliferation
- antigen processing and presentation of exogenous peptide antigen via MHC class II
Molecular Function
- DNA binding
- motor activity
- microtubule motor activity
- protein binding
- ATP binding
Cellular Component
- centrosome
- spindle
- cytosol
- kinesin complex
- plus-end kinesin complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000326047
- Coding exons
- 35
- Length
- 111660
- Individuals with no LoFs
- 125525
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 223
- Defined
- 125748
- p
- 0.000887
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.57 | 567 | 682 | 0.831 | 0.0000346 | 9182 |
| Missense (PolyPhen) | 203 | 276.27 | 0.7348 | 3544 | ||
| Synonymous | 1.53 | 216 | 247 | 0.876 | 0.0000126 | 2453 |
| Loss of Function | 3.15 | 52 | 83.0 | 0.627 | 0.00000432 | 1056 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00056 | 0.00055 | rare |
| Latino/Admixed American | 0.00085 | 0.00075 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00060 | 0.00060 | rare |
| Finnish | 0.0028 | 0.0028 | notable |
| European (Non-Finnish) | 0.00096 | 0.00093 | rare |
| South Asian | 0.00038 | 0.00036 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plus-end directed kinesin-like motor enzyme involved in mitotic spindle assembly. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.0948
Intolerance Scores
- LoFtool
- 0.936
- RVIS EVS
- 1.83
- RVIS percentile EVS
- 97.05
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.694
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |